Evidence map›Paper›PMID 38177302›Full record

ArticleNature microbiology2024

Antagonistic interactions between phage and host factors control arbitrium lysis-lysogeny decision.

Sara Zamora-Caballero, Cora Chmielowska, Nuria Quiles-Puchalt, Aisling Brady, Francisca Gallego Del Sol, Javier Mancheño-Bonillo, Alonso Felipe-Ruíz, Wilfried J J Meijer, José R Penadés, Alberto Marina

Abstract read
In one paragraph

Article in Nature microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Revisiting the life cycle of temperate phages.Nature reviews. Microbiology · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Prophage: agent provocateur?Archives of microbiology · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Ciprofloxacin-driven purifying selection on viral genomes accelerates soil NProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Review
  13. Prokaryotic homeostasis - a solution to thrive and survive.Frontiers in molecular biosciences · 2025
    Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sara Zamora-Caballero *Instituto de Biomedicina de Valencia (IBV)-CSIC and CIBER de Enfermedades Raras (CIBERER)-ISCIII, Valencia, Spain.ORCID 0000-0003-4717-8845
Cora Chmielowska *Centre for Bacterial Resistance Biology, Imperial College London, London, UK.ORCID 0000-0001-7051-3432
Nuria Quiles-Puchalt *Centre for Bacterial Resistance Biology, Imperial College London, London, UK.ORCID 0000-0002-3101-1197
Aisling BradyCentre for Bacterial Resistance Biology, Imperial College London, London, UK.ORCID 0000-0001-5177-4813
Francisca Gallego Del SolInstituto de Biomedicina de Valencia (IBV)-CSIC and CIBER de Enfermedades Raras (CIBERER)-ISCIII, Valencia, Spain.ORCID 0000-0001-9862-4505
Javier Mancheño-BonilloInstituto de Biomedicina de Valencia (IBV)-CSIC and CIBER de Enfermedades Raras (CIBERER)-ISCIII, Valencia, Spain.ORCID 0000-0001-5664-8752
Alonso Felipe-RuízInstituto de Biomedicina de Valencia (IBV)-CSIC and CIBER de Enfermedades Raras (CIBERER)-ISCIII, Valencia, Spain.
Wilfried J J MeijerCentro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Universidad Autónoma, Cantoblanco, Madrid, Spain.ORCID 0000-0003-1842-0049
José R PenadésCentre for Bacterial Resistance Biology, Imperial College London, London, UK. j.penades@imperial.ac.uk.ORCID 0000-0002-6439-5262
Alberto MarinaInstituto de Biomedicina de Valencia (IBV)-CSIC and CIBER de Enfermedades Raras (CIBERER)-ISCIII, Valencia, Spain. amarina@ibv.csic.es.ORCID 0000-0002-1334-5273

Funding

Biotechnology and Biological Sciences Research Council BB/N002873/1Biotechnology and Biological Sciences Research Council BB/S003835/1Biotechnology and Biological Sciences Research Council BB/V002376/1Medical Research Council MR/M003876/1Medical Research Council MR/S00940X/1Medical Research Council MR/V000772/1Wellcome TrustWellcome Trust 201531/Z/16/Z
6 · The paper itself

Abstract

Phages can use a small-molecule communication arbitrium system to coordinate lysis-lysogeny decisions, but the underlying mechanism remains unknown. Here we determined that the arbitrium system in Bacillus subtilis phage phi3T modulates the bacterial toxin-antitoxin system MazE-MazF to regulate the phage life cycle. We show that phi3T expresses AimX and YosL, which bind to and inactivate MazF. AimX also inhibits the function of phi3T_93, a protein that promotes lysogeny by binding to MazE and releasing MazF. Overall, these mutually exclusive interactions promote the lytic cycle of the phage. After several rounds of infection, the phage-encoded AimP peptide accumulates intracellularly and inactivates the phage antiterminator AimR, a process that eliminates aimX expression from the aimP promoter. Therefore, when AimP increases, MazF activity promotes reversion back to lysogeny, since AimX is absent. Altogether, our study reveals the evolutionary strategy used by arbitrium to control lysis-lysogeny by domesticating and fine-tuning a phage-defence mechanism.

Indexed as

Bacillus PhagesLysogenyCell DeathPeptidesPeptides

Identifiers

PMID38177302
PMCPMC10769878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.